GC
BSX icon

Guidance Capital’s Boston Scientific BSX Stock Holding History

Guidance Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$282K Buy
+6,330
New +$344K 0.06% 211
2026
Q1 		– Sell
-4,699
Closed -$429K – 237
2025
Q4 		$429K Buy
4,699
+5
+0.1% +$490 0.1% 169
2025
Q3 		$475K Sell
4,694
-1,100
-19% -$114K 0.12% 160
2025
Q2 		$611K Buy
5,794
+2,015
+53% +$204K 0.17% 123
2025
Q1 		$397K Buy
+3,779
New +$381K 0.12% 155

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return

Guidance Capital's BSX Position: Q2 2026 in Review

Guidance Capital opened a new position in Boston Scientific (BSX) in Q2 2026: 6,330 shares worth $282K. The stake represents 0.06% of the portfolio and ranks #211 among its holdings. This is a return to the name: Guidance Capital previously reported a position in BSX as recently as Q4 2025.

Guidance Capital first reported a position in BSX in Q1 2025 and has held it in 5 quarters since. The position peaked at $611K in Q2 2025. 241 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Guidance Capital held 6,330 shares of Boston Scientific worth $282K as of Q2 2026.
  • Boston Scientific was a new Guidance Capital position in Q2 2026.
  • Boston Scientific made up 0.06% of Guidance Capital's portfolio in Q2 2026, its #211 holding.
  • Guidance Capital first reported a position in Boston Scientific in Q1 2025 and has held it in 5 quarters since.
  • Guidance Capital's Boston Scientific position peaked at $611K in Q2 2025.
  • 241 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Guidance Capital's 13F filing for Q2 2026, filed 20 Jul 2026.